Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
09.03.23
/
50%
€41.80
Target price
09.03.24
€54.81
Performance (%)
45.22%
End price
10.03.24
€60.70
Summary
This prediction ended on 10.03.24 with a price of €60.70. The BUY prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc. saw massive gains of 45.22%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intra-Cellular Therapies Inc. | 4.132% | 4.132% | 9.948% |
iShares Core DAX® | -1.226% | 2.804% | 14.933% |
iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% |
iShares Nikkei 225® | -1.132% | -2.218% | 5.361% |
iShares S&P 500 | -0.980% | 1.883% | 22.727% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten